Legal Opinion

In Re Wellbutrin XL Antitrust Litigation

District Court, E.D. Pennsylvania

Decided December 22, 2010No. Civil Action No. 08-2433. (Indirect)PublishedCited by 22 opinions

1Opinion of the Court 1

MEMORANDUM

McLAUGHLIN, District Judge.

The plaintiffs are a group of indirect purchasers of Wellbutrin XL, a once-a-day antidepressant, who are suing the producers of Wellbutrin XL, Biovail Corp., Biovail Laboratories, Biovail Laboratories International (together, “Biovail”), and its distributors, SmithKline Beecham Corp. and GlaxoSmithKline PLC (together, “GSK”), for illegally conspiring to prevent generic versions of Wellbutrin XL, or buproprion hydrochloride, from entering the American market.

The plaintiffs have moved to amend their complaint to add state law antitrust claims under New…

Also in this document: Opinion of the Court · Scalia.

2Cases cited27 opinions

  1. Erie Railroad v. TompkinsSupreme Court of the United States · 1938
  2. Foman v. DavisSupreme Court of the United States · 1962
  3. Eminence Capital, Llc, and Jay Spechler v. Aspeon, Inc. Richard P. StackCourt of Appeals for the Ninth Circuit · 2003
  4. Marks v. United StatesSupreme Court of the United States · 1977
  5. Marks v. United StatesSupreme Court of the United States · 1977

22 more not listed; retrieve them via the Exa API.

3Cited by22 opinions

  1. Greene v. Gerber Products Co.District Court, E.D. New York · 2017
  2. In re Broiler Chicken Antitrust Litig.District Court, E.D. Illinois · 2017
  3. In Re Digital Music Antitrust LitigationDistrict Court, S.D. New York · 2011
  4. In Re Packaged Ice Antitrust LitigationDistrict Court, E.D. Michigan · 2011
  5. Driscoll v. George Washington UniversityDistrict Court, District of Columbia · 2012

17 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API